TG Therapeutics, Inc. logo TGTX - TG Therapeutics, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY 0
BUY 11
HOLD 1
SELL 1
STRONG
SELL 0
| PRICE TARGET: $54.50 DETAILS
HIGH: $70.00
LOW: $39.00
MEDIAN: $54.50
CONSENSUS: $54.50
UPSIDE: 37.18%

Profitability Ratios

Ratio Value
GP Margin 83.7%
EBIT Margin 21.8%
EBITDA Margin 21.8%
Operating Margin 20.0%
Pretax Margin 17.4%
Cont. Ops Margin 72.6%
Net Margin 72.6%
Bottom Line Margin 72.6%

Liquidity Ratios

Ratio Value
Current Ratio 4.10
Quick Ratio 3.29
Solvency Ratio 1.078
Cash Ratio 0.51

Valuation Ratios

Ratio Value
Price/Earnings
9.62
Hist. avg: 6.4
Peers avg: 23.4
PEG Ratio 0.01
Forward PEG 0.01
Price/Book 6.64
Price/Sales 6.98
Price/FCF -172.18
Price/Op Cash Flow -173.67

Debt Ratios

Ratio Value
Debt/Assets 0.2452
Debt/Equity 0.4024
Debt/Capital 0.2869
Long-Term Debt/Capital 0.2805
Financial Leverage 1.64

Cash Flow Ratios

Ratio Value
Working Capital Turnover 1.29
Operating Cash Flow Ratio -0.161
Operating Cash Flow/Sales -4.0%
Free Cash Flow/Operating Cash Flow 100.9%

Coverage Ratios

Ratio Value
Debt Service Coverage 17.07
Interest Coverage 4.6142
Short-Term Operating Cash Flow Coverage -23.73
Operating Cash Flow Coverage -0.10
Capital Expenditure Coverage -115.76
Dividend + Capital Expenditure Coverage -115.76

Dividend Ratios

Ratio Value
Payout Ratio 0.0000%
Dividend Yield 0.0000%
Dividend Yield % 0.0000%
Dividend Per Share 0.0000

Per Share Ratios

Ratio Value
Revenue/Share 4.27
EPS 3.099
Debt/Share 1.9919
Cash/Share 0.98
Book Value/Share 4.49
Tangible BV/Share 4.49
Equity/Share 4.49
Operating Cash Flow/Share -0.172
Capital Expenditure/Share 0.001
FCF/Share -0.173

Other Ratios

Ratio Value
Net Income/Earnings Before Tax 4.164
Earnings Before Tax/EBIT 0.871
Price/Fair Value 6.64
Debt/Market Cap 0.0590
Effective Tax Rate -316.4%
Enterprise Value Multiple 33.37